Omid Zamani
- Rheumatology top 0.5%
- Immunology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Hematology top 5%
- Oncology top 10%
- Co-authors
- Winn ChathamRonald van VollenhovenDouglas R. HoughAndreas SchwartingZ. John ZhongDaniel J. WallaceDana TegzováRicard Cervera
- Topics
- Rheumatoid Arthritis Research and Therapies (6 papers)Peripheral Neuropathies and Disorders (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)
- Journals
- New England Journal of MedicineAnnals of the Rheumatic DiseasesOsteoarthritis and Cartilage
- Partner nations
- United StatesAustriaSpain
In The Last Decade
Omid Zamani
12 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Rheumatology 1.5k
- Immunology 1.3k
- Radiology, Nuclear Medicine and Imaging 641
- Hematology 261
- Oncology 260
Countries citing papers authored by Omid Zamani
This map shows the geographic impact of Omid Zamani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Zamani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Zamani more than expected).
Fields of papers citing papers by Omid Zamani
This network shows the impact of papers produced by Omid Zamani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Zamani. The network helps show where Omid Zamani may publish in the future.
Co-authorship network of co-authors of Omid Zamani
This figure shows the co-authorship network connecting the top 25 collaborators of Omid Zamani. A scholar is included among the top collaborators of Omid Zamani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Zamani. Omid Zamani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | Baricitinib in Patients with Refractory Rheumatoid Arthritisbreakdown → | 458 |
| 5 | 1 | |
| 6 | 20 | |
| 7 | 4 | |
| 8 | Strontium ranelate prevents radiological progression in patients with primary knee osteoarthritis | 1 |
| 9 | A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA studybreakdown → | 487 |
| 10 | 2 | |
| 11 | 9 | |
| 12 | A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusbreakdown → | 1143 |
About Omid Zamani
Omid Zamani is a scholar working on Rheumatology, Immunology and Genetics, having authored 12 papers that have together received 2.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Peripheral Neuropathies and Disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Rheumatology (1.5k citations), Immunology (1.3k citations) and Radiology, Nuclear Medicine and Imaging (641 citations). Omid Zamani has collaborated with scholars based in United States, Austria and Spain. Frequent co-authors include Winn Chatham, Ronald van Vollenhoven, Douglas R. Hough, Andreas Schwarting, Z. John Zhong, Daniel J. Wallace, Dana Tegzová, Ricard Cervera, William Stohl and Joan T. Merrill. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.